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Abstract 40 
Purpose: The aim was to investigate the effects of tart cherry juice supplementation (TCJ) on 41 
markers of recovery following intermittent exercise, under habitual dietary conditions.  42 
Methods: Using a randomised, single-blind, placebo-controlled, independent groups design, 20 43 
team sport players (n=8 male, n=12 female, age:26 ±4 years, height:175.4 ±9.6cm, body 44 
mass:70.2 ±12.6kg ) were divided equally into two groups and consumed either TCJ or placebo 45 
twice per day for eight consecutive days whilst following their normal dietary habits. 46 
Participants completed an adapted version of the Loughborough Intermittent Shuttle Test 47 
(LIST) on day six of supplementation. Countermovement jump (CMJ), 20m-sprint, maximal 48 
voluntary isometric contraction (MVIC) and muscle soreness (DOMS) were assessed at 49 
baseline, 1h, 24h and 48h post-LIST. Blood markers of muscle damage (CK) and inflammation 50 
(CRP) were taken pre-supplementation, immediately pre-LIST and 1h, 24h and 48h post-LIST. 51 
Data were analysed using a repeated measures ANOVA.  52 
Results: CMJ, 20m-sprint and MVIC showed significantly faster recovery with TCJ (p<0.05) 53 
at 24h and 48h post-LIST. A significant interaction effect (p<0.05) was observed for DOMS; 54 
however, Bonferroni post hoc analysis could not identify when the significant differences 55 
between TCJ and placebo occurred. There were no significant differences throughout recovery 56 
between TCJ and placebo for CRP and CK (p>0.05).  57 
Conclusion: The results suggest that TCJ, in addition to habitual diets, can accelerate recovery 58 
following intermittent exercise and therefore extends the efficacy of TCJ in accelerating 59 
recovery to team sports. 60 
 61 
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 63 
 64 
 65 
 66 
 67 
 68 
 69 
 70 
 71 
 72 
 73 
 74 
 75 
3 
 
Introduction 76 
Participation in athletic training and competition can cause exercise-induced muscle damage 77 
(EIMD).  This phenomenon occurs as a result of mechanical and metabolic stress and is mainly 78 
associated with prolonged, high intensity, eccentric or unaccustomed exercise1. EIMD is 79 
associated with a number of symptoms which include, soreness, a decreased range of motion, 80 
swelling and a reduced ability of the affected muscle to produce force2.  These symptoms can 81 
have a detrimental effect on performance, due to this strategies that can attenuate symptoms 82 
and accelerate recovery are desirable.    83 
  84 
Tart cherry juice (TCJ) supplementation is growing in popularity due to claims 85 
it can aid recovery following damaging exercise due to its potent antioxidant and anti-86 
inflammatory properties3. TCJ contains high concentrations of phytochemicals, including 87 
anthocyanins and flavonoids4. Anthocyanins possess antioxidant and anti-inflammatory 88 
properties and are proposed to scavenge reactive oxygen species (ROS), limit ROS production5 89 
and increase expression of endogenous antioxidant enzymes6. Additionally the anti-90 
inflammatory properties of anthocyanins reduce activity of enzymes such as COX-1, COX-2 91 
and phospholipase A2, thereby reducing the cyclooxygenase, prostaglandin and Inter-Leukin 6 92 
(IL-6) pathway and the proteolytic and lipolytic cascade7. As such, TCJ may attenuate the 93 
inflammatory response and improve recovery following strenuous exercise14.  94 
 95 
The aetiology of resulting muscle damage differs depending on the exercise stimulus, with 96 
endurance modalities associated with high metabolic costs and relatively low mechanical 97 
stress9 compared to eccentric exercise associated with larger mechanical stress10. In contrast to 98 
this, intermittent exercise is shown to induce both metabolic and mechanical stress. However, 99 
it has been proposed that team sports induce significantly less metabolic stress compared to 100 
endurance exercise and less mechanical stress compared to eccentric exercise16.  TCJ has been 101 
shown to be an effective recovery strategy following exercise that induces high metabolic 102 
stress4,12,13,14 and exercise that causes large mechanical stress15,10,16,17.  Therefore, it is likely 103 
that supplementation will also benefit intermittent exercise, where reductions in performance 104 
are likely to be a result of both mechanical and metabolic stress13. 105 
 106 
A few studies have investigated the efficacy of TCJ following intermittent exercise but these 107 
studies have yielded conflicting results. No benefits of TCJ on functional performance, markers 108 
of inflammation (IL-6, CRP) or oxidative stress (uric acid) were demonstrated after water-polo 109 
simulation activity11. In contrast to this, positive effects of TCJ were observed in semi-110 
professional soccer players following the Loughborough Intermittent Shuttle Test 111 
(LIST)13.  Bell et al (2016)13 observed improved recovery of maximal voluntary isometric 112 
contraction (MVIC), counter movement jump (CMJ) and agility alongside attenuated muscle 113 
soreness (DOMS) and reduced concentrations of IL-6 when athletes were supplemented with 114 
TCJ compared to a placebo. However, it is important to consider that athletes were required to 115 
follow a low phenolic diet throughout the study period beginning 48h prior to starting 116 
supplementation.  It is questionable whether the same benefits would occur with TCJ 117 
consumption in addition to the typical diet of an athlete which may 118 
provide sufficient antioxidant and anti-inflammatory nutrients18,19. 119 
 120 
Overall, there is limited research into the benefits of TCJ in aiding recovery and performance 121 
following intermittent exercise and, due to dietary restrictions, current research into team sport 122 
lacks generalisability. Therefore, the current research aims to investigate the efficacy of TCJ 123 
without dietary restrictions, in aiding recovery following intermittent exercise.  If TCJ 124 
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facilitates recovery from intermittent exercise it could be an effective recovery tool for team 125 
players given their crowded training and match schedules. It was hypothesised that 126 
consumption of TCJ for five days before, day of, and two days post a LIST test would attenuate 127 
markers of muscle damage and inflammation and facilitate the return of functional performance 128 
over the 48h recovery period.  129 
 130 
 131 
Methods 132 
Participants 133 
Twenty team-sport players male (n=8) and female (n=12) (football, hockey or netball), 134 
volunteered to participate in the investigation. Participant characteristics are presented in Table 135 
1. Following ethical approval, participants provided written informed consent and completed a 136 
health screening questionnaire. Participants presented for testing in a rested state, without 137 
caffeine or alcohol consumption in the previous 12 and 24 hours respectively, and were asked 138 
to refrain from using anti-inflammatory drugs for the duration of the study.  139 
Experimental Overview 140 
Using a single-blind, independent groups design, participants were randomly allocated to either 141 
a tart cherry juice blend (TCJ) or placebo (PLA) group. Participants attended for testing on four 142 
occasions over nine days. All testing was conducted in a sports hall, and at the same time of 143 
day, in the morning to minimise the effects of circadian rhythm. A standardised warm-up was 144 
conducted at the start of each visit. During the first visit to the laboratory pre-supplementation 145 
blood samples of CK and CRP were obtained.   Participants then completed the multi-stage 146 
fitness test to establish levels, followed by familiarisation with the dependent variables and 147 
one, 15-minute section of the LIST Part-A. 148 
Approximately 7 days later participants returned to the laboratory, baseline data were collected 149 
for the dependent variables CK, CRP, muscle soreness, counter movement jump (CMJ), 20m 150 
sprint and maximum voluntary isometric contraction (MVIC).  This was immediately followed 151 
by completion of an adapted version of the LIST, an intermittent running exercise based on the 152 
physical demands of football13. The adapted LIST consisted of 6x15 minute sections from LIST 153 
Part-A, followed by 12x20m maximal sprints with a 10m deceleration zone, departing every 154 
60s. These adaptations were to account for the stop/start/change of direction nature of team 155 
sports and to standardise distances covered and is a previously used successful protocol for 156 
inducing muscle damage and demonstrating improved recovery with TCJ13. Measurement of 157 
all dependent variables was repeated 1, 24 and 48h post adapted LIST.  158 
Treatment groups 159 
Participants were instructed to consume two servings of TCJ or placebo per day (morning and 160 
evening), for eight consecutive days (five days pre, day of, and two days post-LIST). The TCJ 161 
was a commercially available Montmorency tart cherry concentrate (Holland and Barrett Ltd, 162 
Warwickshire, England). One serving consisted of 30ml TCJ mixed with 70ml of water. This 163 
quantity of TCJ has previously demonstrated improved recovery19. The placebo was a 164 
commercially available, less than 5% fruit content squash (Robinsons Summer Fruits squash, 165 
Britvic plc, Hemel Hempstead, UK) mixed with maltodextrin (MyProtein Ltd, Northwich, UK) 166 
to match the carbohydrate content of the TCJ. One serving consisted of 25ml of squash and 167 
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15g of maltodextrin, mixed with 75ml of water.  Both beverages were matched as closely as 168 
possible for colour and taste. Participants were instructed to follow their normal dietary habits 169 
and keep a food diary for the duration of the study. 170 
 171 
Dependent variables 172 
Muscle soreness was assessed using a 20cm Visual analogue scale (VAS) with ‘no soreness’ 173 
and ‘unbearably painful’ at either end. For each assessment, participants were instructed to 174 
perform a squat and immediately mark their perceived soreness along the scale.  CMJ was 175 
measured using a jump mat (FSL Electronics, Co Tyrone, UK). Participants were instructed to 176 
stand on the mat with feet parallel and shoulder width apart and perform a maximal vertical 177 
jump, maintaining hands on their hips throughout. 20m sprint was timed using infra-red timing 178 
gates (Brower Timing Systems, Utah, USA). MVIC of the non-dominant knee extensors was 179 
measured using a strain gauge (MIE Medical Research Ltd., Leeds, UK). Participants sat on a 180 
platform with their non-dominant ankle attached to the strain gauge, with 90° flexion at the hip 181 
and knee joint. Participants were instructed to maximally extend the knee against the device. 182 
Contractions lasted for approximately three seconds with standardised verbal encouragement 183 
throughout.  Dependent variables were always completed in the above order. Each test, except 184 
DOMS, was performed three times, with one-minute rest between repetitions and three minutes 185 
rest between tests. Peak performance in each test was used for data analysis.  Plasma CK and 186 
CRP were determined using an automated analyser (Rx Daytona, Randox Laboratories Ltd., 187 
Crumlin, Antrim, UK). Normal reference values are 29-200 IU/L for CK and <0.8mg/L for 188 
CRP. Manufacturer’s guidelines report intra-sample coefficient of variation (CV) for CK as 189 
<4% with previous intra-assay CV of 4.3% reported for CRP20. 190 
Statistical analysis 191 
All statistical analyses were performed using SPSS (IBM SPSS statistics 24 Inc, USA) and 192 
reported as mean ± standard deviation. All dependent variables were assessed using a treatment 193 
by time repeated measures analysis of variance (ANOVA). Bonferroni post hoc analysis was 194 
used where significant differences for main effect (trial or time) were found. Statistical 195 
significance was considered when p<0.05. Cohen’s d calculations were used to calculate effect 196 
size to indicate the magnitude of effect on the change from baseline at 1h, 24h and 48h post-197 
LIST. Threshold values were set at 0.2, small; 0.5, moderate; 0.8, large. 198 
Results 199 
Effect sizes and 90% confidence intervals (CI) comparing change from baseline with 1h, 24h 200 
and 48h hours post-LIST are displayed for all dependent variables in Table 2. CK and CRP 201 
were not normally distributed so were log transformed.  202 
 203 
CMJ showed a significant time (F(3,54) =19.250, p=0.001), group (F(1,18) =17.452, p =0.001) and 204 
interaction effect (F(3,54) =6.896, p =0.01).  Post hoc analysis revealed that CMJ was 205 
significantly lower at all time points post-LIST compared to baseline. Additionally, large 206 
between group effect sizes were observed at 24 and 48h post LIST.   CMJ decreased similarly 207 
in both groups 1h post-LIST (TCJ 91.5 ±6.5% of baseline, p =0.007; placebo 88.4 208 
±6.4%, p=0.000) but the return to baseline of CMJ was significantly faster with TCJ when 209 
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compared to PLA at 24h (p =0.02) and 48h (p=0.000). CMJ scores for TCJ returned to baseline 210 
at 48h whereas PLA scores remained suppressed throughout the post-trial period (Figure 1).   211 
 212 
There was a significant time (F(2.157,38.824) =22.433, p=0.000), group (F(1,18) =23.856, p=0.000; 213 
Figure 2) and interaction effect (F(2.157,38.824) =3.292, p =0.044) on 20m sprint. Post hoc analysis 214 
revealed that all time points post-LIST were significantly slower than baseline and the 215 
reduction in speed was significantly greater 1h post-LIST compared to 48h post. Large effect 216 
sizes were observed between groups for changes in 20m sprint times from baseline to 1h post-217 
LIST, 24h and 48h post. Both groups showed similar reductions in speed 1h post-LIST 218 
however, with TCJ the reduction in speed was significantly attenuated at 24h (p =0.004) and 219 
48h (p =0.019) post-LIST. 20m sprint times with TCJ were 1.95 ±2.86% and 0.31 ±1.67% 220 
slower at 24h and 48h respectively, whereas PLA times were 5.94 ±1.94% and 3.84 ±3.34% 221 
slower at 24h and 48h respectively.   222 
 223 
Significant time (F(3,54), =22.484, p˂0.001), group (F(1,18) =7.895, p =0.012)  and interaction 224 
(F(3,54) =7.321, p=0.000)  effects were observed for MVIC (F(3,54), =22.484, p˂0.001). Post 225 
hoc analysis indicated significantly lower scores from baseline occurred at all time points post-226 
LIST (p=0.001) and 1h post-LIST was significantly lower than 48h post (p =0.029). Large 227 
between group effect sizes were also observed at 24 and 48h post list. The decline 1h post-228 
LIST was similar between groups however, with TCJ, the decline in MVIC was significantly 229 
attenuated at 24h (p =0.011) and 48h (p =0.003) post-LIST (Figure 3).   230 
 231 
There was a significant effect of time (F (3,54) =25.787, p=0.000) on DOMS; Bonferroni post 232 
hoc tests indicating significantly higher DOMS scores at all time points after baseline 233 
(p=0.001), with no significant differences between 1h post-LIST, 24h and 48h post (p=0.378, 234 
0.054, 1.000 for 1h and 24h, 1h and 48h, and 24h and 48h; respectively). No significant group 235 
effects (F(1,18) =1.338, p =0.262) were observed however, there was a significant group by time 236 
interaction (F(3,54) =3.850, p =0.014) but further post hoc analysis failed to identify where the 237 
differences were (Table 3). Despite the observations around significance, moderate and large 238 
between group effect sizes were observed for DOMS at 24 and 48h post LIST, respectively.   239 
 240 
With regards to creatine kinase (Figure 4), there was a significant 241 
time effect (F(1.294,19.410) =13.399, p=0.001), with Bonferroni post hoc tests revealing CK was 242 
significantly elevated above pre-supplementation (p=0.07, 0.01, 0.04, for 1h, 24h and 48h 243 
respectively) and pre-LIST levels (p=0.00, 0.04, 0.49, for 1h, 24h and 48h respectively) in both 244 
groups at all time points following the trial. No significant group (F=4.449(1,15), p=0.052) or 245 
interaction (F(1.294,19.410) =0.725, p=0.440) effects were observed.   Whilst no significant group or 246 
interaction effect was observed, moderate effect sizes for between groups were seen at 1 and 247 
24h post LIST.  Although not significant, there was a clear trend for CK concentrations to be 248 
higher 24h post-LIST in the PLA group. At 24h, in comparison to pre-LIST, CRP had increased 249 
by 189.1 ±176.1 IU/L in TCJ vs 378.2 ±345.5 IU/L in PLA.  250 
 251 
The inflammatory marker CRP (Table 3) showed no significant time (F= 2.601(3,27), p=0.073), 252 
group (F=0.140(1,9), p=0.717) or interaction effects (F=0.393(3,27), p=0.759). Effect sizes observed 253 
at 1h and 24h post were small, with 48h post being below threshold levels. Although not 254 
significant, there was a clear trend for CRP concentrations to be higher 24h post-LIST in the 255 
PLA group. At 24h, in comparison to pre-LIST, CRP had increased by 0.933 ±1.437mg/L in 256 
TCJ vs 0.554 ±0.983mg/L in PLA.   257 
 258 
 259 
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 260 
Discussion 261 
The aim of this study was to investigate the efficacy of TCJ without dietary restrictions, on 262 
recovery following intermittent exercise. The main finding was that TCJ supplementation when 263 
compared to a placebo, accelerated recovery in indices of muscle function CMJ, 20m sprint 264 
and MVIC in the 48h recovery period following prolonged intermittent running. Additionally, 265 
there was a trend for reduced concentrations of CK following the LIST.   266 
The decline in one-hour post-LIST functional performance measures were similar between TCJ 267 
and PLA groups, indicating that the initial muscle damage was unaffected by TCJ. However, 268 
the TCJ group showed more rapid recovery of CMJ, 20m-sprint and MVIC performance at 24h 269 
and 48h post-LIST.  This observation was supported by large between group effect sizes, 270 
suggesting TCJ helped attenuate the muscle damage response which likely occurred via the 271 
inflammatory and oxidative stress pathways4,13. These findings are in agreement with 272 
Howatson et al. (2010)4 and Bell et al. (2015)19, reporting that TCJ enhanced recovery of 273 
strength following endurance running and cycling, respectively. Faster recovery of functional 274 
performance has also been previously reported following intermittent running13; however, to 275 
our knowledge the current study is the first to do so without implementation of a low phenolic 276 
diet.  277 
Improved recovery of functional performance with TCJ has been attributed to reduced 278 
inflammation and oxidative damage4. The accelerated return of functional performance in the 279 
current study may be partly attributable to the antioxidant effects of polyphenolic compounds 280 
found in TCJ21,22. Previous research has suggested normal antioxidant defences may only 281 
protect against oxidative stress for less than 24h following exercise4. After this, to prevent 282 
further oxidative stress, increased antioxidant capacity may be needed; potentially provided via 283 
TCJ1.  284 
Supplementation with TCJ resulted in a significant interaction effect for DOMS, although post 285 
hoc analysis could not identify when the significant difference between TCJ and PLA occurred. 286 
Despite this observation, at 24h post-LIST, DOMS increased 255% in the PLA group compared 287 
to 91% in the TCJ group and at 48h post-LIST, DOMS had increased 267% in the PLA group 288 
compared to 44.8% in the TCJ group.  These observations were accompanied by moderate and 289 
large effect sizes at 24 and 48h respectively, indicating that supplementation with TCJ may 290 
have a protective effect.  The experience of DOMS arises as a result of damage to the soft tissue 291 
which leads to an inflammatory response causing swelling in the damaged tissue. The reduction 292 
in soreness observed with TCJ has been attributed to reduced inflammatory and oxidative tissue 293 
damage12. Via inhibition of the COX mediated production of prostaglandins, anthocyanins in 294 
TCJ may limit pain associated with inflammation23.  295 
The findings of this study are consistent with previous research from Bell et al (2016)13 who 296 
demonstrated reduced soreness with TCJ following intermittent running. However it is 297 
important to note that reduced DOMS has not always been observed in research investigating 298 
TCJ15,4,11. Inconsistencies in findings are likely due to differences in study design, with the type 299 
of exercise and training status of participants having a large effect on outcomes. 300 
Given the significant effect of TCJ on functional performance observed within this study it is 301 
surprising that no significant differences between groups were observed for CK and CRP.  In 302 
8 
 
this study CK approached significance (p=0.052) and was accompanied by moderate effect 303 
sizes post exercise. Exercise induced muscle damage is associated with damage to membranes, 304 
partly induced by ROS24. One potential cause for reduced CK levels with TCJ is that ROS-305 
induced membrane damage was attenuated, thus limiting muscle damage and facilitating 306 
recovery of functional performance. Research by Howatson et al. (2010)4, Levers et al. (2016)14 307 
and Bell et al. (2014)18 provides evidence of reduced oxidative stress with TCJ supplementation 308 
indicated via increased total antioxidant status and/or reduced thiobarbituric acid reactive 309 
substances (TBARS) or lipid hydroperoxides (LOOH). However, as the current study did not 310 
measure oxidative stress, the suggestion of TCJ reducing ROS and thus, oxidative 311 
damage/stress, cannot be confirmed.  312 
Several studies have observed reductions in inflammation with the use of TCJ4,19, however this 313 
study failed to observe a significant group difference for CRP. Additionally, no significant time 314 
effect for CRP was observed, thus it is possible that the LIST was not severe enough to cause 315 
an elevated inflammatory response.  In this study, CRP was the only marker of inflammation 316 
that was assessed, future research could look at multiple inflammatory markers to build a better 317 
picture of what is happening with the inflammatory response.  318 
Few studies have investigated the effect of TCJ on simulated team sport activity. Bell et al 319 
(2016)13 observed attenuated symptoms of muscle damage with the use of TCJ following a low 320 
phenolic diet.  Contrasting this McCormick et al (2016)11 observed no beneficial effects of TJC 321 
following a simulated water polo game. However, the authors concluded that the lack of 322 
beneficial effects were due to the non-weight bearing nature of the exercise protocol, which 323 
failed to induce sufficient muscle damage11. This study adds to the body of literature, indicating 324 
that functional performance is improved in athletes without dietary restrictions. However it is 325 
important to highlight that the placebo supplement used within this study contained 5% fruit 326 
juice.  It is possible that this juice contained some phytochemicals and is thus not a true placebo, 327 
this should be noted as a limitation.  328 
Whilst this study demonstrates support for the use of TCJ as a recovery aid, it is important to 329 
note there are concerns that long-term antioxidant supplementation may blunt adaptation to 330 
training25.  Interference effects have been observed in studies investigating supplementation 331 
with antioxidant vitamins C and E26, however, to the author’s knowledge no such findings have 332 
been observed when participants have been supplemented with a functional food such as TCJ.  333 
When recovery rather than adaptation is key, use of TCJ is unlikely to exert detrimental 334 
effects27.  335 
 336 
Practical applications 337 
The results of this study suggest that TCJ, in addition to a ‘normal’ diet, may attenuate the 338 
decline in muscle function associated with muscle damage and therefore facilitate recovery 339 
following simulated team sport. Mohr et al (2016)28 demonstrated that three days of recovery 340 
were inadequate for recovery from game-induced muscle damage and oxidative stress.  The 341 
positive effects of TCJ on functional performance observed within this study has considerable 342 
implications for team sport players who complete intense daily training schedules and matches 343 
often several times a week. Therefore team sport athletes could highly benefit from using TCJ 344 
as a practical and effective strategy to accelerate recovery of muscle function.  In addition to 345 
this, the large improvements observed in CMJ, 20m-sprint and MVIC may also make TCJ an 346 
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attractive supplement for athletes who compete in any strength or power based sport where 347 
there is need for these type of movements.  348 
Conclusion 349 
In conclusion, compared to a placebo, the addition of TCJ to habitual diets for five days pre, 350 
day of and two days post intermittent running, accelerated recovery of functional performance. 351 
This was evidenced by improved CMJ, 20m-sprint and MVIC throughout recovery and 352 
attenuated CK levels at 24h post-LIST. These changes are likely attributable to an attenuated 353 
damage response. This was likely achieved due to the antioxidant and anti-inflammatory 354 
properties of TCJ.  355 
 356 
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Figure 1. Counter-movement jump for the cherry juice and placebo groups at baseline and 
following the LIST. *Significantly greater recovery of CMJ performance was observed in the 
cherry juice group at 24h and 48h post-LIST (p<0.05); values are mean ± SD (n =10 per group). 
 
 
 
Figure 2. 20m sprint times for the cherry juice and placebo groups at baseline and following 
the LIST. * Significantly attenuated decline in 20m sprint in the cherry juice group than the 
placebo at 24h and 48h (p < 0.05); values are mean ± SD (n = 10 per group). 
13 
 
 
Figure 3. Maximal voluntary isometric contraction (MVIC) for the cherry juice and placebo 
groups at baseline and following the LIST. *Significantly greater recovery of force in the 
cherry juice group at 24h and 48h post-LIST (p < 0.05); values are mean ± SD (n = 10 per 
group). 
 
 
 
Figure 4. Serum creatine kinase (CK) concentrations for the cherry juice and placebo groups 
before and following the LIST. Values are mean ± SD (n = 10 per group). 
 
14 
 
Table 1. Participant characteristics. Values are mean ± standard deviations. 
NOTE: =n: number of participants, M/F: male/female, m: metres, kg: kilograms, VO2 max: maximal oxygen uptake. 
 
 
 
 
 
 
 
 
Group Sport 
(=n) 
Sex 
(M/F) 
Age 
(years) 
Height (cm) Mass (kg) Multistage 
Fitness Test 
Level 
Predicted 
VO2 Max 
(ml.kg.min⁻¹) 
 
Cherry juice 
 
Football (n=5) 
Netball (n=3) 
Hockey (n=2) 
 
4/6 
 
28 ± 4 
 
175.9 ± 11.1 
 
 
71.5 ± 13.1 
 
9.4 ± 2.1 
 
44.6 ± 7.2 
 
Placebo 
 
Football (n=9) 
Hockey (n=1) 
 
 
4/6 
 
25 ± 5 
 
174.8 ± 8.4 
 
68.9 ± 12.6 
 
9.3 ± 2.6 
 
44.2 ± 9 
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Table 2. Summary of the differences between cherry juice and placebo for recovery indices 
following intermittent shuttle running 
 Mean difference ± 90% CI Effect Size 
Change from baseline to 
post 
  
CMJ -0.7 ± 0.6 -0.46 (moderate) 
20m sprint 0.1 ± 0.0 0.86 (large) 
MVIC -4.8 ± 17.1 -0.1 
Agility 0.1 ± 0.1 0.35 (small) 
DOMS 14.1 ± 33.8 0.41 (small) 
CK 52.7 ± 31.8 0.61 (moderate) 
CRP -0.3 ± 0.1 -0.41 (small) 
Change from baseline to 
24h 
  
CMJ -2.2 ± 0.6 -1.39 (large) 
20m sprint 0.1 ± 0.0 1.90 (large) 
MVIC -38.4 ± 17.8 -0.79 (large) 
Agility 0.1 ± 0.0 1.24 (large) 
DOMS 31.2 ± 31.8 0.72 (moderate) 
CK 189.1 ± 100.9 0.69 (moderate) 
CRP 0.4 ± 0.2 0.31 (small) 
Change from baseline to 
48h 
  
CMJ -2.7 ± 0.6 -1.67 (large) 
20m sprint 0.1 ± 0.0 1.40 (large) 
MVIC -49.8 ± 15.7 -1.16 (large) 
Agility 0.1 ± 0.2 0.14  
DOMS 54.9 ± 25.2 1.20 (large) 
CK 26.0 ± 61.3 0.16 (small) 
CRP -0.2 ± 0.3 -0.1 
NOTE: Mean difference refers to placebo minus cherry juice trial; 90% CI: 90% confidence 
interval; CMJ: countermovement jump; MVIC: maximal voluntary isometric contraction; 
DOMS: muscle soreness; CK: creatine kinase; CRP: C-reactive protein. 
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Table 3. Mean muscle soreness scores and CRP values for the cherry juice and placebo 
groups before and following intermittent shuttle running.  
 Pre-
supplementation 
Pre-LIST Post-LIST 24h 48h 
DOMS (mm)      
Cherry Juice  43.3 ± 25.9 107.4 ± 36.0 83 ± 26.0 62.7 ± 35.4 
Placebo  27.8 ± 20.0 106 ± 21.4 98.7 ± 31.2 102.1 ± 36.8 
CRP (mg/L)      
Cherry Juice 0.563 ± 0.901 0.277 ± 0.186 0.57 ± 1.034 0.831 ± 1.145 1.201 ± 1.961 
Placebo 1.292 ± 1.756 1.138 ± 1.29 1.176 ± 1.289 2.071 ± 2.03 1.897 ± 1.746 
NOTE: Post-LIST: post Loughborough Intermittent Shuttle Test; DOMS: muscle soreness; 
CRP: C-Reactive Protein. Values are mean ± SD (n=10 per group) 
 
 
 
 
 
